CardioMol is rated 3 out of 5 in the category biotechnology. Read and write reviews about CardioMol. CardioMol provides E2E Drug Discovery Services: from initial targets to drug candidates ready for Preclinical Phase, by using improved structure based in silico drug design with advanced predictions of activity, selectivity and ADMET.
Company size
1-10 employees
Headquarters
Sofia , Sofia-Grad